定制上颌口腔矫治器与下颌前移矫治器治疗中度阻塞性睡眠呼吸暂停患者疗效的对比评价——一项随机对照试验
该前瞻性干预研究纳入40例呼吸暂停低通气指数(AHI)>15-30的中度阻塞性睡眠呼吸暂停(OSA)患者,随机分为下颌前移装置(MAD)组(n=20)与定制上颌口腔矫治器(CMOA)组(n=20)。两组在佩戴矫治器后1个月和3个月复查多导睡眠图,结果显示两组平均AHI、血氧饱和度(SpO2)、呼吸紊乱指数(RDI)及Epworth嗜睡量表(ESS)评分均较基线有统计学显著改善(P<0.001)。作者认为CMOA对中度OSA有效,可作为MAD的一种选择。
要点
- CMOA与MAD均可改善中度OSA患者的AHI、SpO2、RDI和ESS评分。
- 两组各项指标在1个月、1至3个月及基线至3个月比较均有统计学显著差异(P<0.001)。
- 作者认为CMOA对中度OSA有效,可作为MAD治疗中度OSA患者的一种选择。
核心结论
- CMOA对中度OSA有效,具有较大治疗潜力,可作为MAD治疗中度OSA患者的一种选择。
研究设计与样本
- 前瞻性干预研究,纳入40例AHI>15-30的中度OSA患者,随机分为MAD组(n=20)与CMOA组(n=20)。
- 两组均在矫治器交付后1个月和3个月复查多导睡眠图,评估AHI、SpO2、RDI和ESS并与基线比较。
- 统计分析使用SPSS 20.1版,两组间统计学显著性设定为P<0.05。
- 研究在印度临床试验注册中心注册,注册号为CTRI/2020/07/026936,注册日期为2020年7月31日。
主要发现
- 两组平均AHI、SpO2、RDI和ESS评分分析均显示统计学显著结果(P<0.001)。
- 与基线相比,1个月、1至3个月以及基线至3个月比较均显示平均AHI评分统计学显著下降、平均SpO2评分改善、平均RDI评分和ESS评分降低。
临床怎么用
- 原文结论未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obstructive sleep apnea (OSA) is quite common among the adult population, according to recent epidemiological studies. The most frequently suggested alternate treatment for mild to moderate OSA is oral appliances (OA). The purpose of the present study was to assess as well as compare the effectiveness of custom-made maxillary oral appliances against mandibular advancement appliances in the care of individuals suffering from moderate obstructive sleep apnea. METHODS: A prospective interventional research was carried out with 40 participants. Polysomnography (PSG) was done and the participants with an apnea-hypopnea index (AHI) >15-30 were involved in the research. Study participants were randomly split up into two test groups: group I was the "Control Group" (group treated with a mandibular advancement device (MAD), n=20), while group II was exposed to a "customized maxillary oral appliance" (CMOA, n=20). Both groups had reference measures for AHI, blood oxygen saturation (SpO2), oro-nasal airflow via respiratory disturbance index (RDI), and the Epworth Sleepiness Scale (ESS). Appliances were fabricated and delivered to the respective study group participants. PSG was again conducted after a period of 1 and 3 months of appliance delivery and re-evaluation was done for all the parameters and was compared with reference measurements. The facts were analyzed using descriptive and analytical statistical methods. The statistical program utilized in the study was "SPSS (Statistical Package for Social Sciences) Version 20.1." After 1 and 3 months, the statistical significance between the two study groups was assessed at P<0.05. RESULTS: The analysis of mean AHI, SPO2, RDI, and ESS for both test groups manifested statistically significant measures (P<0.001). The study results revealed a statistically significant depletion in mean AHI scores, improvement in mean SPO2 scores, and reduction in mean RDI scores and ESS scores when compared with reference measurements to 1 month, 1 to 3 months, and between reference measurements and 3 months. CONCLUSION: The CMOA was effective in managing moderate OSA and has great therapeutic potential. It can be an option for the MAD for treating patients suffering from moderate obstructive sleep apnea. TRIAL REGISTRATION: The study was registered under Clinical Trials Registry-India and the registration number is CTRI/2020/07/026936 . Registered on 31 July 2020.
引用
- Belkhode V, Godbole S, Nimonkar S, et al. Comparative evaluation of the efficacy of customized maxillary oral appliance with mandibular advancement appliance as a treatment modality for moderate obstructive sleep apnea patients-a randomized controlled trial. Trials. 2023. PMID: 36726182. doi:10.1186/s13063-022-07054-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。